eli lilly small molecule glp 1 Beyond the Needle: Lilly's Orforglipron and the GLP-1 Revolution Eli Lilly's oral GLP-1 pill

But in patients taking GLP-1s, doctors have observed unusual patterns of FDG i.e., hot spots in the body that can mask signs of cancer or make healthy tissue look diseased

The new prescription capability means patients do not need to navigate a prior authorization transfer from their previous branded provider

FDA's April 30, 2026 Proposal On April 30, 2026, the FDA announced a proposal to exclude semaglutide, tirzepatide, and liraglutide from the 503B Bulks List, finding no clinical need for outsourcing facilities to compound these drugs from bulk drug substances when FDA-approved versions are available

Lifestyle interventions remain the foundation of long-term management for both diabetes and obesity